FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3160107679> ?p ?o ?g. }

• W3160107679 abstract "Abstract Background Acute calculous cholecystitis (ACC) is the second most frequent surgical condition in emergency departments. The recommended treatment is the early laparoscopic cholecystectomy; however, the Tokyo Guidelines (TG) advocate for different initial treatments in some subgroups of patients without a strong evidence that all patients will benefit from them. There is no clear consensus in the literature about who is the unfit patient for surgical treatment. The primary aim of the study is to identify the risk factors for mortality in ACC and compare them with Tokyo Guidelines (TG) classification. Methods Retrospective unicentric cohort study of patients emergently admitted with and ACC during 1 January 2011 to 31 December 2016. The study comprised 963 patients. Primary outcome was the mortality after the diagnosis. A propensity score method was used to avoid confounding factors comparing surgical treatment and non-surgical treatment. Results The overall mortality was 3.6%. Mortality was associated with older age (68 + IQR 27 vs. 83 + IQR 5.5; P = 0.001) and higher Charlson Comorbidity Index (3.5 + 5.3 vs. 0 + 2; P = 0.001). A logistic regression model isolated four mortality risk factors (ACME): chronic obstructive pulmonary disease (OR 4.66 95% CI 1.7–12.8 P = 0.001), dementia (OR 4.12; 95% CI 1.34–12.7, P = 0.001), age > 80 years (OR 1.12: 95% CI 1.02–1.21, P = 0.001) and the need of preoperative vasoactive amines (OR 9.9: 95% CI 3.5–28.3, P = 0.001) which predicted the mortality in a 92% of the patients. The receiver operating characteristic curve yielded an area of 88% significantly higher that 68% ( P = 0.003) from the TG classification. When comparing subgroups selected using propensity score matching with the same morbidity and severity of ACC, mortality was higher in the non-surgical treatment group. (26.2% vs. 10.5%). Conclusions Mortality was higher in ACC patients treated with non-surgical treatment. ACME identifies high-risk patients. The validation to ACME with a prospective multicenter study population could allow us to create a new alternative guideline to TG for treating ACC. Trial registration Retrospectively registered and recorded in Clinical Trials. NCT04744441" @default.
• W3160107679 created "2021-05-24" @default.
• W3160107679 creator A5016477867 @default.
• W3160107679 creator A5035517255 @default.
• W3160107679 creator A5037394724 @default.
• W3160107679 creator A5041806727 @default.
• W3160107679 creator A5044969804 @default.
• W3160107679 creator A5050015365 @default.
• W3160107679 creator A5075925016 @default.
• W3160107679 creator A5086858729 @default.
• W3160107679 date "2021-05-11" @default.
• W3160107679 modified "2023-10-09" @default.
• W3160107679 title "Mortality risk estimation in acute calculous cholecystitis: beyond the Tokyo Guidelines" @default.
• W3160107679 cites W1966500936 @default.
• W3160107679 cites W1973216591 @default.
• W3160107679 cites W1979563411 @default.
• W3160107679 cites W2000445173 @default.
• W3160107679 cites W2004550796 @default.
• W3160107679 cites W2036193982 @default.
• W3160107679 cites W2040575800 @default.
• W3160107679 cites W2082727187 @default.
• W3160107679 cites W2125837890 @default.
• W3160107679 cites W2139962519 @default.
• W3160107679 cites W2151247142 @default.
• W3160107679 cites W2159318975 @default.
• W3160107679 cites W2166770030 @default.
• W3160107679 cites W2268346910 @default.
• W3160107679 cites W2313468814 @default.
• W3160107679 cites W2315110338 @default.
• W3160107679 cites W2484403468 @default.
• W3160107679 cites W2529678601 @default.
• W3160107679 cites W2548985045 @default.
• W3160107679 cites W2568189688 @default.
• W3160107679 cites W2582687367 @default.
• W3160107679 cites W2594940232 @default.
• W3160107679 cites W2606541932 @default.
• W3160107679 cites W2607020752 @default.
• W3160107679 cites W2765764102 @default.
• W3160107679 cites W2783715926 @default.
• W3160107679 cites W2791518430 @default.
• W3160107679 cites W2791948890 @default.
• W3160107679 cites W2895277112 @default.
• W3160107679 cites W2896298380 @default.
• W3160107679 cites W2899240368 @default.
• W3160107679 cites W2909558481 @default.
• W3160107679 cites W2914802014 @default.
• W3160107679 cites W2924477332 @default.
• W3160107679 cites W2970729847 @default.
• W3160107679 cites W2982607647 @default.
• W3160107679 cites W2997587274 @default.
• W3160107679 cites W3013964537 @default.
• W3160107679 cites W3015859092 @default.
• W3160107679 cites W3096406900 @default.
• W3160107679 cites W3106973324 @default.
• W3160107679 cites W4245736532 @default.
• W3160107679 cites W4295850237 @default.
• W3160107679 doi "https://doi.org/10.1186/s13017-021-00368-x" @default.
• W3160107679 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8111736" @default.
• W3160107679 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33975601" @default.
• W3160107679 hasPublicationYear "2021" @default.
• W3160107679 type Work @default.
• W3160107679 sameAs 3160107679 @default.
• W3160107679 citedByCount "6" @default.
• W3160107679 countsByYear W31601076792022 @default.
• W3160107679 countsByYear W31601076792023 @default.
• W3160107679 crossrefType "journal-article" @default.
• W3160107679 hasAuthorship W3160107679A5016477867 @default.
• W3160107679 hasAuthorship W3160107679A5035517255 @default.
• W3160107679 hasAuthorship W3160107679A5037394724 @default.
• W3160107679 hasAuthorship W3160107679A5041806727 @default.
• W3160107679 hasAuthorship W3160107679A5044969804 @default.
• W3160107679 hasAuthorship W3160107679A5050015365 @default.
• W3160107679 hasAuthorship W3160107679A5075925016 @default.
• W3160107679 hasAuthorship W3160107679A5086858729 @default.
• W3160107679 hasBestOaLocation W31601076791 @default.
• W3160107679 hasConcept C126322002 @default.
• W3160107679 hasConcept C151956035 @default.
• W3160107679 hasConcept C167135981 @default.
• W3160107679 hasConcept C17923572 @default.
• W3160107679 hasConcept C2777148285 @default.
• W3160107679 hasConcept C2777984932 @default.
• W3160107679 hasConcept C2779159551 @default.
• W3160107679 hasConcept C2780354107 @default.
• W3160107679 hasConcept C71924100 @default.
• W3160107679 hasConcept C77350462 @default.
• W3160107679 hasConceptScore W3160107679C126322002 @default.
• W3160107679 hasConceptScore W3160107679C151956035 @default.
• W3160107679 hasConceptScore W3160107679C167135981 @default.
• W3160107679 hasConceptScore W3160107679C17923572 @default.
• W3160107679 hasConceptScore W3160107679C2777148285 @default.
• W3160107679 hasConceptScore W3160107679C2777984932 @default.
• W3160107679 hasConceptScore W3160107679C2779159551 @default.
• W3160107679 hasConceptScore W3160107679C2780354107 @default.
• W3160107679 hasConceptScore W3160107679C71924100 @default.
• W3160107679 hasConceptScore W3160107679C77350462 @default.
• W3160107679 hasIssue "1" @default.
• W3160107679 hasLocation W31601076791 @default.
• W3160107679 hasLocation W31601076792 @default.
• W3160107679 hasLocation W31601076793 @default.
• W3160107679 hasLocation W31601076794 @default.

• next